+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

Ovarian Hyperstimulation Syndrome - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Ovarian Hyperstimulation Syndrome - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 122 Pages
  • Global
From
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028 - Product Thumbnail Image

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • Report
  • September 2019
  • 162 Pages
  • Global
From
Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • August 2023
  • 739 Pages
  • Global
From
Europe Gynecological Devices Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Assisted Reproduction Technology, Endometrial Ablation Devices, Gynecological Resection Electrodes, and 6 more - Product Thumbnail Image

Europe Gynecological Devices Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Assisted Reproduction Technology, Endometrial Ablation Devices, Gynecological Resection Electrodes, and 6 more

  • Report
  • May 2024
  • 485 Pages
  • Europe
From
South America IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

South America IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 68 Pages
From
South Africa IVF (in-vitro fertilization) Market Overview, 2029 - Product Thumbnail Image

South Africa IVF (in-vitro fertilization) Market Overview, 2029

  • Report
  • May 2024
  • 67 Pages
  • South Africa
From
Saudi Arabia IVF (in-vitro fertilization) Market Overview, 2029 - Product Thumbnail Image

Saudi Arabia IVF (in-vitro fertilization) Market Overview, 2029

  • Report
  • May 2024
  • 67 Pages
  • Saudi Arabia
From
North America IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

North America IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 76 Pages
  • North America
From
Middle East & Africa IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

Middle East & Africa IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 68 Pages
  • Africa, Middle East
From
Europe IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

Europe IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 87 Pages
  • Europe
From
Asia-Pacific IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

Asia-Pacific IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 83 Pages
  • Asia Pacific
From
IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 173 Pages
  • Global
From
Hormone Replacement Therapy Market Outlook, 2029 - Product Thumbnail Image

Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • April 2024
  • 192 Pages
  • Global
From
Premenstrual Syndrome Treatment Market by Drug Type, Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, by 2027 - Product Thumbnail Image

Premenstrual Syndrome Treatment Market by Drug Type, Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, by 2027

  • Report
  • July 2023
  • 221 Pages
  • Global
From
United States Gynecological Devices Market Analysis, Size, Trends 2023-2029 MedSuite Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more. - Product Thumbnail Image

United States Gynecological Devices Market Analysis, Size, Trends 2023-2029 MedSuite Includes: Gynecological Endoscope Devices, Endometrial Ablation Devices, Morcellator Device Market and 7 more.

  • Report
  • July 2023
  • 332 Pages
  • United States
From
Ovarian Cancer Pricing, Reimbursement, and Access - Product Thumbnail Image

Ovarian Cancer Pricing, Reimbursement, and Access

  • Report
  • March 2018
  • 159 Pages
  • Global
From
Ovarian Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Ovarian Cancer Treatment Drugs Companies in China

  • Report
  • August 2024
  • 88 Pages
  • China
From
Ovarian Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Ovarian Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 272 Pages
  • China
From
Polycystic Ovarian Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Polycystic Ovarian Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 47 Pages
  • Global
From
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 39 Pages
  • Global
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more